Abstract

Coronary Artery Disease (CAD) is currently one of the most widespread and deadly conditions in the world. Occurring due to atherosclerosis of the coronary artery and possessing a plethora of risk factors, the disease boasts an extremely large market size which is projected to continue increasing well into the future. Therefore, it is of utmost importance to conduct further research into the management of CAD and utilize this knowledge to develop new products and procedures to decrease its pervasiveness. The biological characteristics of healthy and diseased tissue, global and US market sizes, prevalence, trends, existing treatments, and products in clinical trials relating to CAD are discussed in detail below.

Keywords

coronary artery disease, heart disease, cardiovascular disease, ischemic heart disease, atherosclerosis